Time              One night in 2006, Kathy Roberts rushed her autistic daughter,       Jenny, to the hospital. Nothing had been able to stop the young       woman, then in her mid-20s, from vomiting. Jenny had recently       suffered several major seizures and her entire gastrointestinal       system was going haywire.       
       To try to calm Jenny's GI tract, doctors at Massachusetts General       Hospital prescribed baclofen, an antispasmodic drug that is also       being studied as a potential treatment for alcoholism and other       addictions. The drug relieved Jenny's vomiting, but it did       something else too — a completely unexpected and welcome side       effect. (More on TIME.com: Could Anorexia Be a 'Female' Form of       Autism?)       
       "Within 24 hours, I saw a change," says Roberts. "Right away, I       saw that it was globally calming. I've always described a state       that she would get into where it seemed like she wasn't       comfortable in her own skin, and was trying to crawl out. I saw       that calmed down."       
       Roberts, founder of the Giant Step school for children with autism       in Southport, Conn., called Mark Bear, professor of neuroscience       at MIT and advisory board member of Giant Step. In 2005, Bear had       co-founded a drug company called Seaside Therapeutics to develop       treatments for autism and other developmental disorders. Roberts       told Bear about baclofen's effect on her daughter, and a new line       of research was born. (More on TIME.com: Picky Eating May Be Early       Sign of Autism). [...]